文献速递心外重症与机械循环支持冠心病外科

体外膜氧合作为晚期心力衰竭治疗的桥接

Extracorporeal membrane oxygenation as a bridge to advanced heart failure therapies.
PubMed 文献 · J Heart Lung Transplant · 2023-03-01

该研究基于多中心体外生命支持组织登记数据,分析2016至2021年美国成人因心脏支持或复苏接受VA-ECMO的患者,比较桥接移植意图与非桥接意图患者及2018年前后患者。结果显示,2018年UNOS心脏分配方案实施后,以桥接移植意图使用ECMO并接受LVAD/移植的比例增加,桥接移植意图患者临床急迫性降低,但更急迫的ECMO患者移植尚未增加。

要点

  • 17087例患者中,797例接受LVAD/心脏移植,7931例死亡或预后不良,8359例在ECMO撤除时预期恢复。
  • 桥接移植意图患者临床急迫性低于非桥接候选者,且更可能接受LVAD/移植。
  • 2018年后桥接移植意图患者临床急迫性更低、移植可能性更高,ECMO并发症较2018年前显著减少。

核心结论

  • 2018年UNOS分配系统实施后,ECMO作为桥接移植或LVAD的使用增加,桥接移植意图插管患者的急迫性降低。
  • 更急迫的ECMO患者接受移植尚未增加,这可能部分解释当前时代UNOS报告中ECMO患者的移植后结局。

研究设计与样本

  • 多中心回顾性登记分析,数据来自体外生命支持组织登记,纳入2016至2021年美国成人因心脏支持或复苏接受VA-ECMO的患者。
  • 比较桥接移植意图与非桥接意图患者,以及2018年前后患者的人口学和临床结局预测因素。

主要发现

  • 17087例患者中,797例接受LVAD/心脏移植,7931例死亡或预后不良,8359例在ECMO撤除时预期恢复。
  • 桥接移植意图患者临床急迫性低于非桥接候选者,且更可能接受LVAD/移植。
  • 2018年后,以桥接移植意图接受VA-ECMO并接受LVAD/移植的患者比例增加。
  • 2018年后桥接移植意图患者临床急迫性显著低于2018年后非桥接患者和2018年前桥接移植意图患者,移植可能性显著高于这两组。
  • ECMO并发症与移植可能性降低相关,但2018年后较2018年前显著更少见。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a key support modality for cardiogenic shock. The 2018 United Network for Organ Sharing (UNOS) heart transplant allocation algorithm prioritizes VA-ECMO patients. OBJECTIVE: To evaluate the role of VA-ECMO in bridging to advanced heart failure therapies. METHODS: We analyzed adult patients from the multicenter Extracorporeal Life Support Organization registry receiving VA-ECMO for cardiac support or resuscitation between 2016 and 2021 in the United States, comparing bridge-to-transplant (BTT) and non-BTT intent patients, as well as pre- vs post-2018 patients, on a wide range of demographic and clinical outcome predictors. RESULTS: Of 17,087 patients, 797 received left ventricular assist device (LVAD)/heart transplant, 7,931 died or had poor prognosis, and 8,359 had expected recovery at ECMO discontinuation. Patients supported with BTT intent had lower clinical acuity than non-BTT candidates and were more likely to receive LVAD/transplant. The proportion of patients who received VA-ECMO as BTT and received LVAD/transplant increased after 2018. Post-2018 BTT patients had significantly lower clinical acuity and higher likelihood of transplant than both post-2018 non-BTT patients and pre-2018 BTT patients. ECMO complications were associated with lower likelihood of transplant but were significantly less common post-2018 than pre-2018. CONCLUSIONS: After implementation of the 2018 UNOS allocation system, ECMO utilization as BTT or LVAD has increased, and the acuity of BTT intent patients cannulated for ECMO has decreased. There has not yet been an increase in more acute ECMO patients getting transplanted. This may partially explain the post-transplant outcomes of ECMO patients in the current era reported in UNOS.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Acharya D, Manandhar-Shrestha N, Leacche M, et al. Extracorporeal membrane oxygenation as a bridge to advanced heart failure therapies. J Heart Lung Transplant. 2023. PMID: 36964083. doi:10.1016/j.healun.2023.02.1498

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。